ArticleBioinformatics (Oxford, England)2018
Learning with multiple pairwise kernels for drug bioactivity prediction.
Article in Bioinformatics (Oxford, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed.
- KAN-GIN: Adaptive Nonlinear Molecular Representation Learning for Drug-Target Affinity Prediction.Pharmaceuticals (Basel, Switzerland) · 2026Article
- GraphTransDTA: Drug-Target Affinity Prediction with Graph Transformer for Multimodal Data Fusion.Interdisciplinary sciences, computational life sciences · 2026Article
- Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery.Cancer research · 2026Article
- MMPCS: multi-view molecular pretraining based on consistency information and specific information.Bioinformatics (Oxford, England) · 2026Article
- Benchmarking heterogeneous network-based methods for drug repurposing.NPJ systems biology and applications · 2025Article
- AΙ-Driven Drug Repurposing: Applications and Challenges.Medicines (Basel, Switzerland) · 2025Review
- A technical review of multi-omics data integration methods: from classical statistical to deep generative approaches.Briefings in bioinformatics · 2025Review
- GS-DTA: integrating graph and sequence models for predicting drug-target binding affinity.BMC genomics · 2025Article
- Drug-target binding affinity prediction based on power graph and word2vec.BMC medical genomics · 2025Article
- MolMVC: Enhancing molecular representations for drug-related tasks through multi-view contrastive learning.Bioinformatics (Oxford, England) · 2024Article
- Leveraging multiple data types for improved compound-kinase bioactivity prediction.Nature communications · 2024Article
- A review of deep learning methods for ligand based drug virtual screening.Fundamental research · 2024Review
- GEFormerDTA: drug target affinity prediction based on transformer graph for early fusion.Scientific reports · 2024Article
- Integrating molecular, biochemical, and immunohistochemical features as predictors of hepatocellular carcinoma drug response using machine-learning algorithms.Frontiers in molecular biosciences · 2024Article
- DGDTA: dynamic graph attention network for predicting drug-target binding affinity.BMC bioinformatics · 2023Article
- Dose-response prediction for in-vitro drug combination datasets: a probabilistic approach.BMC bioinformatics · 2023Article
- Drug-target interaction prediction based on protein features, using wrapper feature selection.Scientific reports · 2023Article
- GraphATT-DTA: Attention-Based Novel Representation of Interaction to Predict Drug-Target Binding Affinity.Biomedicines · 2022Article
- Deep reinforcement learning for personalized treatment recommendation.Statistics in medicine · 2022Article
- Machine learning for multi-omics data integration in cancer.iScience · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Many inference problems in bioinformatics, including drug bioactivity prediction, can be formulated as pairwise learning problems, in which one is interested in making predictions for pairs of objects, e.g. drugs and their targets. Kernel-based approaches have emerged as powerful tools for solving problems of that kind, and especially multiple kernel learning (MKL) offers promising benefits as it enables integrating various types of complex biomedical information sources in the form of kernels, along with learning their importance for the prediction task. However, the immense size of pairwise kernel spaces remains a major bottleneck, making the existing MKL algorithms computationally infeasible even for small number of input pairs. Results: We introduce pairwiseMKL, the first method for time- and memory-efficient learning with multiple pairwise kernels. pairwiseMKL first determines the mixture weights of the input pairwise kernels, and then learns the pairwise prediction function. Both steps are performed efficiently without explicit computation of the massive pairwise matrices, therefore making the method applicable to solving large pairwise learning problems. We demonstrate the performance of pairwiseMKL in two related tasks of quantitative drug bioactivity prediction using up to 167 995 bioactivity measurements and 3120 pairwise kernels: (i) prediction of anticancer efficacy of drug compounds across a large panel of cancer cell lines; and (ii) prediction of target profiles of anticancer compounds across their kinome-wide target spaces. We show that pairwiseMKL provides accurate predictions using sparse solutions in terms of selected kernels, and therefore it automatically identifies also data sources relevant for the prediction problem. Availability and implementation: Code is available at https://github.com/aalto-ics-kepaco. Supplementary information: Supplementary data are available at Bioinformatics online.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.